Paul Tudor Jones’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$432K Sell
5,100
-16,900
-77% -$1.36M ﹤0.01% 2924
2026
Q1
$1.56M Buy
+22,000
New +$1.65M ﹤0.01% 2042
2025
Q4
Sell
-5,300
Closed -$437K 3825
2025
Q3
$437K Sell
5,300
-7,100
-57% -$559K ﹤0.01% 2769
2025
Q2
$997K Buy
12,400
+2,100
+20% +$162K ﹤0.01% 2128
2025
Q1
$827K Buy
10,300
+1,200
+13% +$99.8K ﹤0.01% 1938
2024
Q4
$745K Buy
+9,100
New +$757K ﹤0.01% 1944
2024
Q2
Sell
-17,300
Closed -$1.28M 2601
2024
Q1
$1.28M Sell
17,300
-32,200
-65% -$2.24M 0.01% 1219
2023
Q4
$3.27M Buy
49,500
+42,300
+588% +$2.65M 0.03% 850
2023
Q3
$453K Sell
7,200
-9,800
-58% -$610K ﹤0.01% 1726
2023
Q2
$961K Buy
+17,000
New +$943K 0.01% 1339

Other funds holding MET

Paul Tudor Jones's MET Position: Q2 2026 in Review

Paul Tudor Jones sold out of MetLife (MET) in Q2 2026, closing a stake of 70,474 shares — an estimated $5.68M sold.

Paul Tudor Jones first reported a position in MET in Q3 2014 and held it in 33 quarters. The position peaked at $31.5M in Q2 2023. 1,438 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Paul Tudor Jones reported no remaining MetLife position as of Q2 2026 after selling out during the quarter.
  • Paul Tudor Jones sold 70,474 MetLife shares in Q2 2026, an estimated $5.68M.
  • Paul Tudor Jones first reported a position in MetLife in Q3 2014 and held it in 33 quarters.
  • Paul Tudor Jones's MetLife position peaked at $31.5M in Q2 2023.
  • 1,438 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.